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Cancer Statistics in Korea: Incidence, Mortality and Survival  
in 2006-2007
Cancer has been the leading cause of death in Korea. Korea is facing a very rapid change 
and increase in cancer incidence, which draws much attention in public health. This paper 
overviews the nationwide cancer statistics, including incidence, mortality, and survival rates, 
and their trends in Korea based on the cancer incidence data from The Korea Central 
Cancer Registry (KCCR) in year 2006 and 2007. In Korea, there were 153,237 cancer cases 
and 65,519, cancer deaths observed in 2006, and 161,920 cancer cases and 67,561 cancer 
deaths in 2007, respectively. The incidence rate for all cancer combined showed an annual 
increase of 2.8% from 1999 to 2007. Specifically, there was significant increase in the 
incidence of colorectal, thyroid, female breast, and prostate cancers. The number of cancer 
deaths has increased over the past two decades, due mostly to population aging, while the 
age-standardized mortality rates have decreased in both  men and women since 2002. 
Notable improvement has been observed in the 5-yr relative survival rates for most major 
cancers and for all cancer combined, with the exception of pancreatic cancer. The 
nationwide cancer statistics in this paper will provide essential data for cancer research and 
evidence-based health policy in Korea. 
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SPECIAL ARTICLE
Oncology & Hematology
INTRODUCTION
Cancer has been the leading cause of death in Korea since 1983 
(1) and poses a major public health concern. Over 150,000 new 
cancer cases are diagnosed annually in Korea and one out of 
four deaths results from cancer (2, 3). This paper gives an over-
view of the nationwide cancer statistics, including the incidence, 
mortality, and survival rates, and their trends in Korea. This re-
port is a part of Special Article series that presents the annually 
updated nationwide cancer statistics in Korea since 2009 (4). 
MATERIALS AND METHODS
Data sources
The Korea Ministry of Health and Welfare started a nationwide, 
hospital-based cancer registry called the Korea Central Cancer 
Registry (KCCR) in 1980. Details of the history, objectives, and 
activities of the KCCR have been documented (5). Incidence 
data from 1999 to 2007 were obtained from the Korea National 
Cancer Incidence Database (KNCIDB). Cancer cases were clas-
sified according to the International Classification of Diseases 
for Oncology 3rd edition (6) and converted to the International 
Classification of Diseases 10th edition (ICD-10) (7). The survival 
analysis used 1,302,353 cancer cases first diagnosed during 
1993-2007 from the KNCIDB, and followed vital status through 
31 December 2008.
 Mortality data from 1983 to 2007 were obtained from the Ko-
rea National Statistics Office (KNSO) (1). Cause of death was 
coded and classified according to the ICD-10. The population 
data were also obtained from KNSO using the resident registra-
tion population on 1 July each year.
 Crude rates (CRs) and age-specific rates of cancer incidence 
and mortality were calculated. Age-standardized rates (ASRs) 
were determined using the World Health Organization (WHO) 
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world standard population (8). The cumulative risks of cancer 
incidence, which are the probability of developing cancer to the 
life expectancy, were also calculated. Changes in the annual age-
standardized cancer incidence rates were examined by calcu-
lating the annual percentage change (APC) over a time period 
as 100(e-1), where e is the slope of the regression of log age-stan-
dardized rates on a calendar year (9).
 The survival duration of each case was determined as the time 
difference between the date of initial diagnosis and the date of 
death, date of loss to follow-up, or closing date for follow-up. 
Observed survival rates were calculated using a life table meth-
od and relative survival rates were examined with the Ederer II 
method (10) using an algorithm written in SAS by Paul Dick-
man (11), with some minor adaptations. 
 
RESULTS AND DISCUSSION
Incidence
Table 1 presents the number of new cancer cases during 2006-
2007 in Korea by sex and cancer site. 153,237 new cancer cases 
in 2006, 161,920 new cancer cases in 2007 were observed in Korea. 
The cumulative risks for developing a cancer to the life expec-
tancy were 34.6%, 34.4% for men and 27.3%, 28.9% for women 
during 2006 and 2007, respectively.
 Table 2 ranks cancer incidence by sex during 2006-2007. The 
CRs of all sites combined in 2006 were 334.7 and 292.1 per 100,000 
in men and women, respectively, and the ASRs of all sites com-
bined were 307.4 and 215.0 per 100,000. The CRs of all sites com-
bined in 2007 were 346.2 and 312.8 per 100,000 in men and wom-
en, respectively, and the ASRs of all sites combined were 305.9 
and 224.9 per 100,000. In males, the five leading primary sites of 
cancer were the stomach (CR 70.4, ASR 61.2), lung (CR 52.1, ASR 
47.5), colon & rectum (CR 49.7, ASR 43.5), liver (CR 45.2, ASR 
38.4), and prostate (CR 21.5, ASR 20.0), accounting for 69.0% of 
all newly diagnosed cancers in 2007. In females, the most com-
mon cancer sites were the thyroid (CR 73.5, ASR 55.6), breast 
(CR 47.4, ASR 34.7), stomach (CR 35.0, ASR 23.9), colon & rec-
tum (CR 33.9, ASR 23.4), lung (CR 20.4, ASR 13.3), and liver (CR 
15.4, ASR 10.7), accounting for 72.1% of all newly diagnosed can-
cers. Thyroid cancer alone accounts for 23.5% (18,019) of inci-
dent cases in women in 2007.
 From the construction of a KNCIDB for 1999 onward to 2007, 
the completeness of the Korea Cancer Registry data has improv-
ed gradually. This might have contributed in part to the gradual 
Table 1. Number of cancer  cases and deaths by sex during 2006-2007 in Korea
Site
2006 2007
New cases Deaths New cases Deaths
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
All sites 153,237 82,027 71,210 65,519 41,841 23,678 161,920 85,257 76,663 67,561 42,778 24,783 
Lip, oral cavity, & pharynx    2,263   1,671      592      892     695      197     2,312   1,712      600      949      746      203 
Esophagus    2,036   1,869      167   1,476   1,351      125     2,035   1,840      195   1,449   1,320      129 
Stomach  26,253 17,633   8,620 10,716   7,051   3,665   25,915 17,337   8,578 10,563   6,875   3,688 
Colon & rectum 19,570 11,473   8,097   6,195   3,406   2,789   20,558 12,242   8,316   6,608   3,739   2,869 
Liver 14,877 11,147   3,730 10,884   8,240   2,644   14,924 11,141   3,783 11,144   8,389   2,755 
Gallbladder*   4,057   2,077   1,980   3,385   1,712   1,673     4,149   2,066   2,083   3,408   1,662   1,746 
Pancreas   3,771   2,078   1,693   3,445   1,890   1,555     3,937   2,197   1,740   3,569   1,917   1,652 
Larynx   1,054      978        76      522      468        54     1,072   1,009        63      490      441        49 
Lung 17,578 12,612   4,966 14,027 10,447   3,580   17,846 12,841   5,005 14,278 10,545   3,733 
Breast 10,805        52 10,753   1,615       17   1,598   11,639        33 11,606   1,678          8   1,670 
Cervix uteri   3,999 -   3,999   1,002 -   1,002     3,616 -   3,616      987 -      987 
Corpus uteri   1,280 -   1,280      146 -      146     1,324 -   1,324      165 -      165 
Ovary   1,663 -   1,663      712 -      712     1,838 -   1,838      825 -      825 
Prostate   4,425   4,425 -   1,004   1,004 -     5,292   5,292 -   1,107   1,107 -
Testis      182      182 -        14        14 -        175      175 -        22      22 -
Kidney   2,634   1,794     840      673      477      196     2,846   1,967      879      715    474      241 
Bladder   3,022   2,451     571      920      699      221     3,097   2,464      633      948    700      248 
Brain & CNS   1,542      809     733   1,126      596      530     1,594      845      749   1,157    636      521 
Thyroid 16,414   2,383 14,031      334        89      245   21,178   3,159 18,019      380    107      273 
Hodgkin’s disease      171      105       66        44        32        12        197      124        73        36      22        14 
Non-Hodgkin’s lymphoma   3,194   1,822  1,372   1,222      734      488    3,244   1,875   1,369   1,289    792      497 
Multiple myeloma      758      380     378      541      297      244       853      440       413      613    297      316 
Leukemia   2,393   1,316  1,077   1,410      842      568    2,375   1,328    1,047   1,447    824      623 
Other & ill-defined   9,296   4,770  4,526   3,214   1,780   1,434    9,904   5,170   4,734   3,734 2,155   1,579 
*Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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overall increases in cancer incidence, especially among the el-
derly. 
Mortality
A total of 65,519 cancer deaths were reported in Korea, account-
ing for about 27.0% of all deaths in 2006 (Table 3). In 2007, can-
cer deaths (67,561 cases) account for 27.6% of all deaths. The CRs 
of all sites combined in 2006 were 170.7 and 97.1 per 100,000 
for men and women, respectively, and the ASRs of all sites com-
bined were 161.9 and 65.3 per 100,000. In 2007, the CRs of all 
sites combined were 173.7 and 101.1 per 100,000 for men and 
women, respectively, and the ASRs of all sites combined were 
158.2 and 65.6 per 100,000. Cancers of the lung, liver, stomach 
and colon & rectum were the most common fatal cancers, which 
accounted for about 63% of all cancer deaths in 2007 (Table 4).
 In men, the five leading primary cancer sites for mortality of 
the year of 2007 were the lung (CR 42.8, ASR 39.5), liver (CR 34.1, 
ASR 29.3), stomach (CR 27.9, ASR 25.3), colon & rectum (CR 
15.2, ASR 14.0), and pancreas (CR 7.8, ASR 7.1). In women, lung 
cancer mortality (CR 15.2, ASR 9.4) has increased gradually, was 
the first cancer sites for mortality in 2007, following stomach (CR 
15.0, ASR 9.3), colon & rectum (CR 11.7, ASR 7.3, liver (CR 11.2, 
ASR 7.5), and gallbladder (CR 7.1, ASR 4.3).
Trends in cancer incidence
Table 5-1~5-3 show the trends in cancer incidence for all sites 
combined and for selected cancer sites. The incidence rate for 
all sites combined increased by 2.8% annually from 1999 to 2007. 
The incidence rate for all sites combined increased by 1.3% an-
nually in men and by 4.7% in women from 1999 to 2007.
 The incidence rates have continued to increase for colorectal 
and thyroid cancer in both sexes, along with breast cancer in 
females and prostate cancer in males. Stomach and lung can-
cer incidence rates plateaued in men and women, while the in-
cidences of liver cancer in both sexes and the cervical cancer in 
women have decreased.
 One notable aspect is the sharp increase (25.7% annually) in 
the incidence of female thyroid cancer. As diagnostic techniques 
for thyroid cancer have become more sensitive, such as the ad-
vent of ultrasound and fine-needle aspiration, the detection of 
subclinical disease has become possible. Therefore, the increas-
ed incidence of thyroid cancer might reflect improved diagnos-
tic techniques for previously undetected disease, rather than a 
true increase in the occurrence of thyroid cancer (12, 13). 
Table 2. Crude and age-standardized cancer incidence rates by sex during 2006-2007 in Korea 
Site
2006 2007
Crude incidence rates per 
100,000
Age-standardized incidence 
rates per 100,000*
Crude incidence rates per 
100,000
Age-standardized incidence 
rates per 100,000*
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
All sites 313.5 334.7 292.1 249.9 307.4 215.0 329.6 346.2 312.8 254.5 305.9 224.9 
Lip, oral cavity, & pharynx     4.6     6.8     2.4     3.7     6.1     1.8     4.7     7.0     2.4     3.7     6.0     1.8 
Esophagus     4.2     7.6     0.7     3.4     7.2     0.5     4.1     7.5     0.8     3.2     6.7     0.5 
Stomach   53.7   72.0  35.4   42.6   64.9   24.9   52.7   70.4   35.0   40.4   61.2   23.9 
Colon & rectum   40.0   46.8  33.2   32.0   42.7   23.7   41.8   49.7   33.9   32.3   43.5   23.4 
Liver   30.4   45.5  15.3   24.4   39.9   11.0   30.4   45.2   15.4   23.5   38.4   10.7 
Gallbladder†     8.3     8.5    8.1     6.5     8.0     5.4     8.4     8.4     8.5     6.4     7.7     5.4 
Pancreas     7.7     8.5    6.9     6.1     7.9     4.7     8.0     8.9     7.1     6.1     8.0     4.6 
Larynx     2.2     4.0    0.3     1.8     3.7     0.2     2.2     4.1     0.3     1.7     3.6     0.2 
Lung   36.0   51.5  20.4   28.4   48.9   13.8   36.3   52.1   20.4   27.5   47.5   13.3 
Breast   22.1     0.2  44.1   16.8     0.2   33.0   23.7     0.1   47.4   17.6     0.1   34.7 
Cervix uteri     8.2 -  16.4     6.3 -   12.1     7.4 -   14.8     5.5 -   10.7 
Corpus uteri     2.6 -    5.3     2.1 -     4.0     2.7 -     5.4     2.1 -     4.0 
Ovary     3.4 -    6.8     2.7 -     5.3     3.7 -     7.5     2.9 -     5.7 
Prostate     9.1   18.1 -     7.2   17.7 -   10.8   21.5 -     8.3   20.0 -
Testis     0.4     0.7 -     0.4     0.7 -     0.4     0.7 -     0.3     0.7 -
Kidney     5.4     7.3    3.4     4.4     6.4     2.7     5.8     8.0     3.6     4.6     6.8     2.7 
Bladder     6.2   10.0    2.3     4.9     9.5     1.6     6.3   10.0     2.6     4.8     9.0     1.6 
Brain & CNS     3.2     3.3    3.0     2.9     3.1     2.6     3.2     3.4     3.1     3.0     3.3     2.7 
Thyroid   33.6     9.7  57.6   25.9     7.7   44.1   43.1   12.8   73.5   32.8     9.9   55.6 
Hodgkin’s disease     0.3     0.4    0.3     0.3     0.4     0.3     0.4     0.5     0.3     0.4     0.5     0.3 
Non-Hodgkin’s lymphoma     6.5     7.4    5.6     5.4     6.8     4.3     6.6     7.6     5.6     5.3     6.7     4.2 
Multiple myeloma     1.6     1.6    1.6     1.3     1.4     1.1     1.7     1.8     1.7     1.3     1.6     1.2 
Leukemia     4.9     5.4    4.4     4.8     5.5     4.3     4.8     5.4     4.3     4.7     5.5     4.0 
Other & ill-defined   19.0   19.5  18.6   15.8   18.5   13.7   20.2   21.0   19.3   16.2   19.2   13.9
*Age adjusted to the WHO world standard population; †Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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Table 3. Ten leading causes of death during 2006-2007 in Korea
Rank Cause of death Number of deaths Percent of all deaths Age-standardized death rate*
Year 2006
  1
  2
  3
  4
  5
  6
  7
  8
  9
10
All causes
Cancer
Cerebrovascular disease
Heart disease
Diabetes mellitus
Intentional self harm (suicide)
Transport accidents
Disease of liver
Chronic lower respiratory diseases
Hypertensive diseases
Pneumonia
Others
242,266 
  65,519 
  29,951 
  20,101 
  11,564 
  10,653 
    7,784 
    7,583 
    7,061 
    4,606 
    4,544 
  72,900 
100.0 
  27.0 
  12.4 
    8.3 
    4.8 
    4.4 
    3.2 
    3.1 
    2.9 
    1.9 
    1.9 
  30.1 
395.6 
105.3 
  46.6 
  31.8 
  18.2 
  17.4 
  13.6 
  12.1 
  10.9 
    7.2 
    7.3 
125.1 
Year 2007
  1
  2
  3
  4
  5
  6
  7
  8
  9
10
All causes
Cancer
Cerebrovascular disease
Heart disease
Intentional self harm (suicide)
Diabetes mellitus
Transport accidents
Chronic lower respiratory diseases
Disease of liver
Hypertensive diseases
Pneumonia
Others
244,874 
  67,561 
  29,277 
  21,494 
  12,174 
  11,272 
    7,604 
    7,523 
    7,314 
    5,402 
    4,556 
  70,697 
100.0 
  27.6 
  12.0 
    8.8 
    5.0 
    4.6 
    3.1 
    3.1 
    3.0 
    2.2 
    1.9 
  28.9 
382.1 
103.9 
  43.2 
  32.4 
  19.6 
  16.8 
  12.9 
  11.0 
  11.3 
    8.0 
    6.9 
116.0
*Age adjusted to the WHO world standard population. Source: Mortality Data, Korea National Statistical Office, 2008.
Table 4. Crude and age-standardized cancer mortality rates by sex during 2006-2007 in Korea
Site
2006 2007
Crude mortality rates per 
100,000
Age-standardized mortality 
rates per 100,000*
Crude mortality rates per 
100,000
Age-standardized mortality 
rates per 100,000*
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
Both 
sexes
Males Females
All sites 134.0 170.7   97.1 105.3 161.9 65.3 137.5 173.7 101.1 103.9 158.2 65.6 
Lip, oral cavity, & pharynx     1.8     2.8     0.8     1.4     2.6   0.5     1.9     3.0     0.8     1.5     2.7   0.6 
Esophagus     3.0     5.5     0.5     2.4     5.3   0.3     2.9     5.4     0.5     2.2     4.9   0.3 
Stomach   21.9   28.8   15.0   16.9   27.2   9.7   21.5   27.9   15.0   15.9   25.3   9.3 
Colon & rectum   12.7   13.9   11.4     9.8   13.3   7.4   13.4   15.2   11.7   10.1   14.0   7.3 
Liver   22.3   33.6   10.8   17.7   29.9   7.5   22.7   34.1   11.2   17.5   29.3   7.5 
Gallbladder†     6.9     7.0     6.9     5.4     6.8   4.4     6.9     6.7     7.1     5.1     6.3   4.3 
Pancreas     7.0     7.7     6.4     5.5     7.3   4.2     7.3     7.8     6.7     5.5     7.1   4.2 
Larynx     1.1     1.9     0.2     0.8     1.9   0.1     1.0     1.8     0.2     0.7     1.7   0.1 
Lung   28.7   42.6   14.7   22.4   41.2   9.4   29.1   42.8   15.2   21.7   39.5   9.4 
Breast     3.3     0.1     6.6     2.6     0.1   4.8     3.4     0.0     6.8     2.6 0.0   4.9 
Cervix uteri     2.0 -     4.1     1.6 -   2.8     2.0 -     4.0     1.5 -   2.7 
Corpus uteri     0.3 -     0.6     0.2 -   0.4     0.3 -     0.7     0.3 -   0.5 
Ovary     1.5 -     2.9     1.1 -   2.1     1.7 -     3.4     1.2 -   2.3 
Prostate     2.1     4.1 -     1.6     4.5 -     2.3     4.5 -     1.6     4.6 -
Testis     0.0     0.1 -     0.0     0.0 -     0.0     0.1 -     0.0     0.1 -
Kidney     1.4     1.9     0.8     1.1     1.8   0.5     1.5     1.9     1.0     1.1     1.8   0.7 
Bladder     1.9     2.9     0.9     1.4     2.9   0.5     1.9     2.8     1.0     1.4     2.8   0.6 
Brain & CNS     2.3     2.4     2.2     2.0     2.3   1.7     2.4     2.6     2.1     1.9     2.4   1.6 
Thyroid     0.7     0.4     1.0     0.5     0.4   0.6     0.8     0.4     1.1     0.6     0.4   0.7 
Hodgkin’s disease     0.1     0.1     0.0     0.1     0.1   0.0     0.1     0.1     0.1     0.1     0.1   0.0 
Non-Hodgkin’s lymphoma     2.5     3.0     2.0     2.0     2.8   1.4     2.6     3.2     2.0     2.0     2.9   1.3 
Multiple myeloma     1.1     1.2     1.0     0.9     1.1   0.7     1.2     1.2     1.3     0.9     1.1   0.9 
Leukemia     2.9     3.4     2.3     2.6     3.3   1.9     2.9     3.3     2.5     2.6     3.2   2.1 
Other & ill-defined     6.6     7.3     5.9     5.3     7.0   4.1     7.6     8.8     6.4     5.9     8.1   4.3
*Age adjusted to the WHO world standard population; †Includes gallbladder and other/unspecified parts of biliary tract. CNS, central nervous system.
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Table 5-1. Trends in cancer incidence rates in both sexes during 1999-2007 in Korea
Site
Year
APC*
1999 2000 2001 2002 2003 2004 2005 2006 2007
All sites 210.5 205.1 216.7 220.1 226.3 233.5 246.2 249.9 254.5 2.8† 
Lip, oral cavity, & pharynx 3.6 4.4 3.6 3.7 3.8 3.7 3.7 3.7 3.7 -0.4 
Esophagus 4.1 3.7 3.9 3.8 3.6 3.5 3.5 3.4 3.2 -2.4† 
Stomach 43.6 42.3 44.0 43.6 43.1 41.0 44.2 42.6 40.4 -0.6 
Colon & rectum 20.4 21.0 22.9 24.7 26.6 28.3 30.7 32.0 32.3 6.6† 
Liver 27.9 26.7 27.3 26.5 25.7 25.5 25.7 24.4 23.5 -1.9†
Gallbladder‡ 6.5 6.4 6.7 6.7 6.6 6.9 7.1 6.5 6.4 0.2 
Pancreas 5.6 5.5 5.5 5.8 5.8 6.0 6.3 6.1 6.1 1.5†
Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.7 -3.9†
Lung 28.5 27.7 28.3 28.5 27.8 28.7 28.8 28.4 27.5 0.0 
Breast 10.7 10.8 12.7 13.9 14.1 14.8 16.0 16.8 17.6 6.6† 
Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.8 6.4 6.3 5.5 -5.0† 
Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.1 5.8† 
Ovary 2.7 2.5 2.5 2.6 2.6 2.7 2.8 2.7 2.9 1.6†
Prostate 3.1 2.7 3.6 3.9 4.7 5.9 6.2 7.2 8.3 15.0†
Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 3.2† 
Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.6 6.0† 
Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.0 4.9 4.8 0.7 
Brain & CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.1 2.9 3.0 0.9 
Thyroid 6.3 6.1 7.9 9.5 12.7 17.4 21.0 25.9 32.8 25.2† 
Hodgkin’s disease 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 4.2† 
Non-Hodgkin’s lymphoma 4.5 4.2 4.5 4.6 4.9 5.2 5.2 5.4 5.3 3.2† 
Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.3 4.0 
Leukemia 4.7 4.3 4.7 4.8 4.7 4.8 4.7 4.8 4.7 0.6 
Other & ill-defined 14.3 13.5 13.9 13.5 14.9 14.9 15.8 15.8 16.2 -
*APC, annual percent change using age-standardized incidence based on the WHO world standard population; †The APC is significantly different from zero (P<0.05); ‡Includes 
gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
Table 5-2. Trends in cancer incidence rates in males during 1999-2007 in Korea
Site
Year
APC*
1999 2000 2001 2002 2003 2004 2005 2006 2007
All sites 285.0 276.7 288.3 290.0 293.3 297.6 309.6 307.4 305.9 1.3† 
Lip, oral cavity, & pharynx 6.1 7.1 6.0 6.2 6.5 6.1 6.0 6.1 6.0 -0.9 
Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 6.7 -2.7† 
Stomach 66.2 65.0 67.2 66.6 65.7 62.1 66.6 64.9 61.2 -0.7 
Colon & rectum 26.2 27.2 29.6 32.9 35.0 37.5 40.8 42.7 43.5 7.2† 
Liver 46.8 44.7 45.1 43.9 42.2 42.0 42.5 39.9 38.4 -2.1† 
Gallbladder‡ 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.0 7.7 0.1 
Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 7.9 8.0 0.6 
Larynx 4.9 4.5 5.1 4.7 4.4 4.1 4.3 3.7 3.6 -3.8†
Lung 51.4 49.8 51.1 51.0 49.8 50.7 50.7 48.9 47.5 -0.7† 
Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 -4.8 
Prostate 8.4 7.2 9.5 10.1 12.2 14.8 15.5 17.7 20.0 13.4†
Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 3.2† 
Kidney 4.5 4.4 4.9 5.0 5.1 5.5 6.0 6.4 6.8 5.6†
Bladder 9.0 9.0 9.4 9.0 9.6 9.7 9.7 9.5 9.0 0.5 
Brain & CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.4 3.1 3.3 0.8 
Thyroid 2.1 1.9 2.4 2.7 3.6 4.9 6.0 7.7 9.9 23.7†
Hodgkin’s disease 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 2.5 
Non-Hodgkin’s lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.4 6.8 6.7 2.6†
Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.4 1.6 2.8†
Leukemia 5.5 5.0 5.4 5.8 5.4 5.6 5.5 5.5 5.5 0.5 
Other & ill-defined 17.9 16.5 16.8 16.5 18.2 17.9 18.9 18.5 19.2 -
*APC, annual percent change using age-standardized incidence based on the WHO world standard population; †The APC is significantly different from zero (P<0.05); ‡Includes 
gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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Trends in cancer mortality
Figs. 1, 2 show the trends in cancer deaths for all sites combined 
and for selected cancer sites. Age-standardized mortality rates 
have decreased for all sites combined in both sexes since 2002. 
Lung cancer surpassed stomach cancer as the leading cause of 
cancer death in 1999, and is expected to account for 21.1% of all 
cancer deaths in 2007. The age-standardized mortality rates of 
lung cancer has decreased slightly for men since 2001, but in-
creased in women. The age-standardized mortality rates of stom-
ach and cervix uteri cancer have decreased continuously. Along 
with the significant increases in colorectal, prostate and female 
breast cancer incidence, the mortality rates of these cancers have 
also continued to increase.
Age-specific incidence rates for selected cancer sites
Table 6 presents the most common cancer sites by sex and age 
group in 2006-2007. Leukemia and thyroid were the most com-
mon forms in both sexes, for ages 0-14 and 15-34 yr, respective-
ly. For males, stomach cancer was the most common in 35-64- 
yr-olds, while lung cancer was more frequent for those aged 65 
and older. For females, the most common sites of cancer were 
the thyroid for the 35-64-yr-old. For the 65 and over age groups, 
colorectal cancer was the second common sites in 2006, was 
most common cancer sites in 2007.
 Fig. 3 shows the age-specific incidence rates of the selected 
cancers for men and women in 2007. The data show that the in-
cidence of stomach, lung, liver and colorectal cancers increased 
gradually with age. In women, the age-specific incidence rates 
of breast and thyroid cancer has increased with age until the 
Table 5-3. Trends in cancer incidence rates in females during 1999-2007 in Korea
Site
Year
APC*
1999 2000 2001 2002 2003 2004 2005 2006 2007
All sites 161.1 157.4 169.0 174.6 183.1 192.5 206.5 215.0 224.9 4.7† 
Lip, oral cavity, & pharynx 1.6 2.4 1.7 1.7 1.7 1.8 1.9 1.8 1.8 0.0 
Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 -2.8† 
Stomach 26.7 25.2 26.2 26.3 25.8 24.6 26.8 24.9 23.9 -0.9 
Colon & rectum 16.4 16.4 17.9 18.8 20.4 21.3 22.7 23.7 23.4 5.3†
Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.3 11.0 10.7 -1.6† 
Gallbladder‡ 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.4 5.4 0.2 
Pancreas 4.0 4.0 4.0 4.2 4.4 4.4 4.7 4.7 4.6 2.4†
Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 -9.5† 
Lung 12.4 12.5 12.3 12.6 12.3 13.0 13.4 13.8 13.3 1.3† 
Breast 20.9 20.9 24.7 27.2 27.7 29.0 31.5 33.0 34.7 6.8† 
Cervix uteri 16.3 15.1 15.8 14.8 14.1 13.0 12.3 12.1 10.7 -4.8† 
Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.0 6.0†
Ovary 5.0 4.8 4.8 5.0 5.1 5.1 5.4 5.3 5.7 1.8† 
Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.7 6.2† 
Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.6 0.0 
Brain & CNS 2.6 2.5 2.5 2.4 2.5 2.6 2.8 2.6 2.7 1.0 
Thyroid 10.4 10.1 13.2 16.2 21.7 29.9 35.8 44.1 55.6 25.7† 
Hodgkin’s disease 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 6.8†
Non-Hodgkin’s lymphoma 3.4 3.2 3.4 3.5 3.9 4.1 4.3 4.3 4.2 4.0†
Multiple myeloma 0.8 0.8 0.9 0.8 0.9 1.0 1.2 1.1 1.2 5.6† 
Leukemia 3.9 3.8 4.1 4.0 4.1 4.0 4.0 4.3 4.0 0.8 
Other & ill-defined 11.8 11.5 11.8 11.5 12.5 12.7 13.6 13.7 13.9 -
*APC, annual percent change using age-standardized incidence based on the WHO world standard population; †The APC is significantly different from zero (P<0.05); ‡Includes 
gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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Fig. 1. Age-standardized cancer incidence and death rates for all sites by sex during 
1983-2007 in Korea.
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Fig. 2. Age-standardized cancer mortality for selected cancers by sex during 1983-2007 in Korea.
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Fig. 3. Age-specific incidence rates of major cancers during 2007 in Korea.
Table 6. Five major sites of cancer incidence by age group and sex during 2006-2007 in Korea
Rank
2006 2007
0-14 yr 15-34 yr 35-64 yr 65 yr and over 0-14 yr 15-34 yr 35-64 yr 65 yr and over 
Males 
1
2
3
4
5
Leukemia (4.3)
Brain & CNS (2.0)
Non-Hodgkin’s 
lymphoma (1.7)
Kidney (0.5)
Testis  
(0.4)
Thyroid (4.8)
Stomach (3.6)
Leukemia  
(2.8)
Non-Hodgkin’s 
lymphoma (2.6)
Colon & rectum 
(2.4)
Stomach (92.0)
Liver (71.3)
Colon & rectum 
(59.2)
Lung (44.4)
Thyroid  
(17.1)
Lung (456.9)
Stomach (453.4)
Colon & rectum 
(298.6)
Liver (211.9)
Prostate  
(187.3)
Leukemia (4.5 )
Brain & CNS (2.4)
Non-Hodgkin’s 
lymphoma (1.4)
Kidney (0.3)
Testis  
(0.3)
Thyroid (6.2)
Leukemia (3.0)
Stomach  
(2.9)
Non-Hodgkin’s 
lymphoma (2.7)
Colon & rectum 
(2.1)
Stomach (87.9)
Liver (67.2)
Colon & rectum 
(60.8)
Lung 
(40.5)
Thyroid (22.3)
Lung (456.9) 
Stomach (422.3)
Colon & rectum 
(305.2)
Liver  
(211.8)
Prostate 
(209.9)
Females
1
2
3
4
5
Leukemia  
(4.0)
Brain & CNS  
(2.1)
Non-Hodgkin’s 
lymphoma (0.7)
Ovary  
(0.6)*
Kidney (0.6)*
Thyroid  
(29.6)
Breast  
(9.2)
Stomach  
(5.0)
Cervix uteri  
(4.8)
Ovary (2.6)
Thyroid  
(105.9)
Breast  
(87.9)
Stomach  
(39.4)
Colon & rectum 
(38.1)
Cervix uteri (26.2)
Stomach  
(159.1)
Colon & rectum 
(152.5)
Lung  
(117.6)
Liver  
(74.2)
Gallbladder† (50.3)
Leukemia  
(3.8)
Brain & CNS  
(1.9)
Non-Hodgkin’s 
lymphoma (0.8)
Ovary  
(0.7)
Kidney (0.5)
Thyroid  
(35.3)
Breast  
(9.8)
Stomach  
(4.7)
Cervix uteri  
(4.7)
Ovary (3.0)
Thyroid  
(135.1)
 Breast  
(92.8)
Stomach  
(37.8)
Colon & rectum 
(36.7)
Cervix uteri (23.4)
Colon & rectum 
(154.4) 
Stomach  
(153.6) 
Lung  
(113.7) 
Liver  
(74.5) 
Thyroid (55.6)
*Same ranks with equal number of incident cases in ovary and kidney cancers for 0-14 yr age group in 2006; †Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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forties and leveled off.
Survival rates
Table 7 shows the 5-yr relative survivals for four different peri-
ods: 1993-1995, 1996-2000, 2001-2005 and 2003-2007. Notable 
improvement has been made in the 5-yr relative survival rates 
for all cancer sites combined. The 5-yr survival in females ap-
peared to be higher than in males, and this can be partly ex-
plained by the high frequency of cancers in females that are 
known to have relatively good prognoses (e.g., thyroid, breast 
and uterine cervix).
 The 5-yr relative survival rates appeared to be higher for most 
major cancer sites in patients diagnosed during 2003-2007 com-
pared to 1993-1995, except for cancers of the pancreas. The great-
est improvements were seen in prostate cancer, stomach can-
cer, leukemia, non-Hodgkin’s lymphoma. The improving sur-
vival rates could be attributable to early detection, as well as to 
improved treatments (14, 15), but this needs to be evaluated 
further. Lack of progress in early detection and treatment could 
explain the observed absence of improvement in the survival 
rate of pancreatic cancer (16).
Table 7. Trends in the 5-yr relative survival rates (%) by year of diagnosis during 1993-2007 in Korea
Site
Males Females
1993-1995 1996-2000 2001-2005 2003-2007 Change* 1993-1995 1996-2000 2001-2005 2003-2007 Change*
All sites 31.7 35.3 44.6 48.3 16.6 53.4 55.3 63.3 67.1 13.7
Lip, oral cavity, & pharynx 35.8 41.1 48.7 50.9 15.1 58.1 63.8 67.0 68.3 10.2
Esophagus 11.8 14.3 20.0 23.1 11.3 23.7 24.2 29.0 31.8   8.1
Stomach 43.0 46.9 58.1 62.1 19.1 42.6 46.0 55.7 59.5 16.9
Colon & rectum 55.3 59.0 68.0 70.4 15.1 54.2 56.8 63.6 66.4 12.2
Liver 9.9 12.9 19.5 21.8 11.9 13.6 14.2 19.3 21.5   7.9
Gallbladder† 16.6 20.3 22.8 24.4   7.8 18.0 19.1 21.4 22.5   4.5
Pancreas   8.8   7.3   7.5   7.7  -1.1 10.1 8.1   7.4   7.5 -2.6
Larynx 60.2 62.8 66.2 68.1   7.9 55.4 57.8 57.4 60.4   5.0
Lung 10.4 11.6 14.4 15.2   4.8 14.2 16.2 19.0 21.0   6.8
Breast 75.1 85.6 88.5 88.1 13.0 78.0 83.2 88.0 89.5 11.5
Cervix uteri - - - - - 77.5 80.0 80.9 80.5   3.0
Corpus uteri - - - - - 81.5 81.8 84.5 85.5   4.0
Ovary - - - - - 58.7 58.9 61.0 60.2   1.5
Prostate 55.9 67.2 78.6 82.4 26.5 - - - - -
Testis 85.4 90.4 90.4 90.5   5.1 - - - - -
Kidney 60.8 64.4 72.3 74.7 13.9 64.5 69.7 74.1 75.3 10.8
Bladder 70.0 74.8 77.4 78.3   8.3 65.5 66.3 67.9 69.2   3.7
Brain & CNS 37.2 37.5 39.3 40.6   3.4 40.2 40.7 40.7 41.2   1.0
Thyroid 87.2 89.5 95.3 96.9   9.7 95.4 95.9 98.4 99.2   3.8
Hodgkin’s disease 67.6 68.1 73.6 75.0   7.4 68.6 77.4 79.8 83.5 14.9
Non-Hodgkin’s lymphoma 45.3 48.9 57.1 58.2 12.9 48.7 53.5 62.0 64.2 15.5
Multiple myeloma 21.1 17.8 28.8 30.7 9.6 23.3 22.1 27.7 30.0   6.7
Leukemia 26.2 32.3 40.8 42.8 16.6 26.8 34.6 41.0 43.6 16.8
Other & ill-defined 37.4 42.4 50.7 53.5 16.1 47.4 50.0 58.4 62.8 15.4
*Change in the 5-yr relative survival between 1993-1995 and 2003-2007 as a percentage; †Includes gallbladder and other/unspecified parts of biliary tract.
CNS, central nervous system.
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